BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29725412)

  • 1. Locally advanced laryngeal cancer: Total laryngectomy or primary non-surgical treatment?
    Čoček A; Ambruš M; Dohnalová A; Chovanec M; Kubecová M; Licková K
    Oncol Lett; 2018 May; 15(5):6701-6708. PubMed ID: 29725412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage- and subsite-specific survival analysis.
    Cervenka BP; Rao S; Farwell DG; Bewley AF
    Clin Otolaryngol; 2018 Apr; 43(2):544-552. PubMed ID: 29054118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
    Varghese BT; Sebastian P; Mathew A
    Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx--results of a pilot study.
    Thakar A; Bahadur S; Tandon DA; Ranganathan A; Rath GK
    J Laryngol Otol; 1999 May; 113(5):433-8. PubMed ID: 10505156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
    Li ZD; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
    León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers.
    Clayman GL; Weber RS; Guillamondegui O; Byers RM; Wolf PF; Frankenthaler RA; Morrison WH; Garden AS; Hong WK; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):219-23. PubMed ID: 7840931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.
    Su X; He HC; Ye ZL; Zhou DL; Liu Q; Yang XH; Long YK; Tang T; Ma JJ; Xu BH; Chen WC; He CY; Yang AK
    Front Oncol; 2020; 10():535893. PubMed ID: 33178574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
    B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
    Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
    Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer.
    Stanković M; Milisavljević D; Stojanov D; Zivić M; Zivaljević S; Stanković I; Petrović S
    Coll Antropol; 2012 Nov; 36 Suppl 2():7-12. PubMed ID: 23397747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
    Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
    Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage.
    Koss SL; Russell MD; Leem TH; Schiff BA; Smith RV
    Laryngoscope; 2014 Feb; 124(2):421-8. PubMed ID: 24323309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.